1. Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med. 2006. 4:23.
2. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol. 2007. 42:Suppl 18. 39–41.
3. Lin YJ, Chen PC, Chen HA, Li CF. IgG4-related retroperitoneal fibrosis: the first reported case in a Chinese population. Int J Rheum Dis. 2010. 13:e70–e73.
4. Minato N, Takayama H, Mukai M, Miyagawa Y, Tsujihata M, Nonomura N, et al. A case report of retroperitoneal fibrosis associated with IgG4-related sclerosing disease. Hinyokika Kiyo. 2010. 56:371–375.
5. Kim KY, Kim DK, Woo SH, Kim ET, Lee SB. Laparoscopic partial nephrectomy: an useful method of decision making for determining the approach and surgical method based on the systematic classification of tumor location. Korean J Urol. 2008. 49:1067–1073.
6. Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol. 2011. 23:88–94.
7. Van Moerkercke W, Verhamme M, Meeus G, Oyen R, Steenbergen WV. A case of IgG4-related sclerosing disease with retroperitoneal fibrosis, autoimmune pancreatitis and bilateral focal nephritis. Pancreas. 2009. 38:825–832.